Literature DB >> 10519937

Immunization of dogs with a DNA vaccine induces protection against rabies virus.

P Perrin1, Y Jacob, A Aguilar-Sétien, E Loza-Rubio, C Jallet, E Desmézières, M Aubert, F Cliquet, N Tordo.   

Abstract

Rabies is a fatal encephalomyelitis which is transmitted to man, mostly by dogs in developing countries. This zoonosis can be prevented by vaccination of humans before or after exposure. However, a more radical approach is possible, involving the elimination of the principal vector/reservoir by vaccinating dogs. The vaccine must be effective, safe and inexpensive. Mass production of plasmids is possible and DNA-based immunization with a plasmid encoding the antigen responsible for inducing protection seems to be more cost-effective than classical techniques involving cell culture. Beagles were immunized by intramuscular (i.m.) injection with a plasmid encoding the rabies virus (PV strain) glycoprotein. Neutralizing antibodies against both wild-type rabies virus and European Bat Lyssaviruses (EBL1 and EBL2) were detected after a single injection and a boost, but levels of neutralizing antibodies against EBL1 were low. Moreover, all vaccinated dogs were protected against a lethal challenge with a wild-type dog rabies strain. This is one of the first studies to demonstrate that dogs can be protected by DNA vaccines, and opens important perspectives for rabies control.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519937     DOI: 10.1016/s0264-410x(99)00247-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Quantifying antigenic relationships among the lyssaviruses.

Authors:  D L Horton; L M McElhinney; D A Marston; J L N Wood; C A Russell; N Lewis; I V Kuzmin; R A M Fouchier; A D M E Osterhaus; A R Fooks; D J Smith
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

2.  Risks related to a possible reduction of the waiting period for dogs after rabies antibody titration to 30 days compared with 90 days of the current EU legislative regime.

Authors:  Julio Alvarez; Søren Saxmose Nielsen; Emmanuelle Robardet; Arjan Stegeman; Steven Van Gucht; Vlad Vuta; Sotiria-Eleni Antoniou; Inma Aznar; Alexandra Papanikolaou; Helen Clare Roberts
Journal:  EFSA J       Date:  2022-06-02

3.  Immunogenicity and efficacy of Rabivac vaccine for animal rabies control in Morocco.

Authors:  Sami Darkaoui; Ouafaa Fassi Fihri; Jean Luc Schereffer; Nadia Aboulfidaa; Marine Wasniewski; Karima Zouine; Mohammed Bouslikhane; Khadija Id Sidi Yahia; Florence Cliquet
Journal:  Clin Exp Vaccine Res       Date:  2016-01-27

Review 4.  Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential.

Authors:  Shimao Zhu; Caiping Guo
Journal:  Viruses       Date:  2016-10-28       Impact factor: 5.048

Review 5.  Lyssaviruses: current trends.

Authors:  Susan A Nadin-Davis; Christine Fehlner-Gardiner
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

6.  Vaccination and monitoring strategies for epidemic prevention and detection in the Channel Island fox (Urocyon littoralis).

Authors:  Jessica N Sanchez; Brian R Hudgens
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

7.  Development in Immunoprophylaxis against Rabies for Animals and Humans.

Authors:  Sukdeb Nandi; Manoj Kumar
Journal:  Avicenna J Med Biotechnol       Date:  2010-01

8.  Rabies DNA vaccine: no impact of MHC class I and class II targeting sequences on immune response and protection against lethal challenge.

Authors:  Manpreet Kaur; Anant Rai; Rakesh Bhatnagar
Journal:  Vaccine       Date:  2009-02-06       Impact factor: 3.641

9.  Vaccination in Leishmaniasis: A Review Article.

Authors:  Latifeh Abdellahi; Fariba Iraji; Anahita Mahmoudabadi; Seyed Hossein Hejazi
Journal:  Iran Biomed J       Date:  2022-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.